Cardiopulmonary Autotransfusion Devices Market Size By Application, Industry Analysis Report, Regional Outlook (North America, Europe, Asia Pacific, Middle East & Africa, And South America), Growth Potential, Price Trends, Competitive Market Share & Forecast 2023 - 2030 (Recession Impact Analysis)
ID : MRU_
2073 | Date :
Jan, 2023 | Pages :
180 | Region : Global |
Publisher : 99 Strategy
Autotransfusion is also known as intraoperative blood salvage. It is a process in which blood is collected from active bleeding site of patient and rein fused into the same patient during cardiac surgery. Several commercial autotransfusion devices are available in market. There are three types of autotransfusion system namely; continuous flow centrifugal system, discontinuous flow centrifugal system and unwashed blood filter system. The unwashed blood filter system for autotransfusion is more popular than other systems because it is inexpensive system and easy to use. This technology had led to increased use of centrifugation devices for blood collection. During cardiopulmonary bypass (CPB) blood is collected from patient active bleeding site by the help of suckers in different ways. This blood is collected in cardiotomy reservoir and it is filtered in this reservoir. Then this blood is redirected to venous reservoir where it is oxygenated and finally it is returned to patient body.
Heart Association, globally over 80 million people suffer from heart health problems. This is occurring due to change in life style of people and consumption of high amount of fats and sugar. The complication in allogenic blood transfusion which results in significant loss of blood during cardiac surgery has led to the rise in demand for cardiopulmonary autotransfusion systems. Beside that innovation in the autotransfusion system due to advancement in technology has also boosted the global market of cardiopulmonary autotransfusion devices.
The Global Cardiopulmonary Autotransfusion Devices Market had reached xxx million USD with a CAGR xx from 2018-2022. Later on, it will go to xxx million USD in 2023 with a CAGR xx % from 2023-2030.
In the global Cardiopulmonary Autotransfusion Devices Market, This report focuses particularly in North America, South America, Europe and Asia-Pacific, and Middle East and Africa. This report classifies the Market on the basis of application, type, regions, and manufactures.
In Market segmentation by manufacturers, the report covers the following companies-
Fresenius Kabi
Haemonetics
LivaNova
Medtronic
Terumo
Stryker
Atrium Medical
In Market segmentation by geographical regions, the report has analysed the following regions-
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Columbia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
In Market segmentation by types :
On-Pump Transfusion Device
Off-Pump Transfusion Device
In Market segmentation by applications :
Hospitals
Ambulatory Surgical Center
Cardiac Research Centers
The research provides answers to the following key questions:
• What is the estimated growth rate and Market share and size of the Cardiopulmonary Autotransfusion Devices Market for the forecast period 2023-2030?
• What are the driving forces in the Cardiopulmonary Autotransfusion Devices Market for the forecast period 2023-2030?
• Who are the prominent Market players and how have they gained a competitive edge over other competitors?
• What are the Market trends influencing the progress of the Cardiopulmonary Autotransfusion Devices industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the Market hold for the prominent Market players? Any special requirements about this report, please let us know and we can provide custom report.
Note – In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.
Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Cardiopulmonary Autotransfusion Devices Market Size Growth Rate by Type (2020-2030)
1.3.2 On-Pump Transfusion Device
1.3.3 Off-Pump Transfusion Device
1.4 Market Segment by Application
1.4.1 Global Cardiopulmonary Autotransfusion Devices Market Share by Application (2020-2030)
1.4.2 Hospitals
1.4.3 Ambulatory Surgical Center
1.4.4 Cardiac Research Centers
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Production and Capacity Analysis
2.1.1 Global Cardiopulmonary Autotransfusion Devices Production Value 2015-2030
2.1.2 Global Cardiopulmonary Autotransfusion Devices Production 2015-2030
2.1.3 Global Cardiopulmonary Autotransfusion Devices Capacity 2015-2030
2.1.4 Global Cardiopulmonary Autotransfusion Devices Marketing Pricing and Trends
2.2 Key Producers Growth Rate (CAGR) 2020-2030
2.2.1 Global Cardiopulmonary Autotransfusion Devices Market Size CAGR of Key Regions
2.2.2 Global Cardiopulmonary Autotransfusion Devices Market Share of Key Regions
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Capacity and Production by Manufacturers
3.1.1 Global Cardiopulmonary Autotransfusion Devices Capacity by Manufacturers
3.1.2 Global Cardiopulmonary Autotransfusion Devices Production by Manufacturers
3.2 Revenue by Manufacturers
3.2.1 Cardiopulmonary Autotransfusion Devices Revenue by Manufacturers (2018 - 2022)
3.2.2 Cardiopulmonary Autotransfusion Devices Revenue Share by Manufacturers (2018 - 2022)
3.2.3 Global Cardiopulmonary Autotransfusion Devices Market Concentration Ratio (CR5 and HHI)
3.3 Cardiopulmonary Autotransfusion Devices Price by Manufacturers
3.4 Key Manufacturers Cardiopulmonary Autotransfusion Devices Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Cardiopulmonary Autotransfusion Devices Market
3.6 Key Manufacturers Cardiopulmonary Autotransfusion Devices Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Production and Production Value for Each Type
4.1.1 On-Pump Transfusion Device Production and Production Value (2018 - 2022)
4.1.2 Off-Pump Transfusion Device Production and Production Value (2018 - 2022)
4.2 Global Cardiopulmonary Autotransfusion Devices Production Market Share by Type
4.3 Global Cardiopulmonary Autotransfusion Devices Production Value Market Share by Type
4.4 Cardiopulmonary Autotransfusion Devices Ex-factory Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Cardiopulmonary Autotransfusion Devices Consumption by Application
6 Production by Regions
6.1 Global Cardiopulmonary Autotransfusion Devices Production (History Data) by Regions 2018 - 2022
6.2 Global Cardiopulmonary Autotransfusion Devices Production Value (History Data) by Regions
6.3 United States
6.3.1 United States Cardiopulmonary Autotransfusion Devices Production Growth Rate 2018 - 2022
6.3.2 United States Cardiopulmonary Autotransfusion Devices Production Value Growth Rate 2018 - 2022
6.3.3 Key Players in United States
6.3.4 United States Cardiopulmonary Autotransfusion Devices Import & Export
6.4 European Union
6.4.1 European Union Cardiopulmonary Autotransfusion Devices Production Growth Rate 2018 - 2022
6.4.2 European Union Cardiopulmonary Autotransfusion Devices Production Value Growth Rate 2018 - 2022
6.4.3 Key Players in European Union
6.4.4 European Union Cardiopulmonary Autotransfusion Devices Import & Export
6.5 China
6.5.1 China Cardiopulmonary Autotransfusion Devices Production Growth Rate 2018 - 2022
6.5.2 China Cardiopulmonary Autotransfusion Devices Production Value Growth Rate 2018 - 2022
6.5.3 Key Players in China
6.5.4 China Cardiopulmonary Autotransfusion Devices Import & Export
6.6 Rest of World
6.6.1 Japan
6.6.2 Korea
6.6.3 India
6.6.4 Southeast Asia
7 Cardiopulmonary Autotransfusion Devices Consumption by Regions
7.1 Global Cardiopulmonary Autotransfusion Devices Consumption (History Data) by Regions
7.2 United States
7.2.1 United States Cardiopulmonary Autotransfusion Devices Consumption by Type
7.2.2 United States Cardiopulmonary Autotransfusion Devices Consumption by Application
7.3 European Union
7.3.1 European Union Cardiopulmonary Autotransfusion Devices Consumption by Type
7.3.2 European Union Cardiopulmonary Autotransfusion Devices Consumption by Application
7.4 China
7.4.1 China Cardiopulmonary Autotransfusion Devices Consumption by Type
7.4.2 China Cardiopulmonary Autotransfusion Devices Consumption by Application
7.5 Rest of World
7.5.1 Rest of World Cardiopulmonary Autotransfusion Devices Consumption by Type
7.5.2 Rest of World Cardiopulmonary Autotransfusion Devices Consumption by Application
7.5.1 Japan
7.5.2 Korea
7.5.3 India
7.5.4 Southeast Asia
8 Company Profiles
8.1 Fresenius Kabi
8.1.1 Fresenius Kabi Company Details
8.1.2 Company Description and Business Overview
8.1.3 Production and Revenue of Cardiopulmonary Autotransfusion Devices
8.1.4 Cardiopulmonary Autotransfusion Devices Product Introduction
8.1.5 Fresenius Kabi Recent Development
8.2 Haemonetics
8.2.1 Haemonetics Company Details
8.2.2 Company Description and Business Overview
8.2.3 Production and Revenue of Cardiopulmonary Autotransfusion Devices
8.2.4 Cardiopulmonary Autotransfusion Devices Product Introduction
8.2.5 Haemonetics Recent Development
8.3 LivaNova
8.3.1 LivaNova Company Details
8.3.2 Company Description and Business Overview
8.3.3 Production and Revenue of Cardiopulmonary Autotransfusion Devices
8.3.4 Cardiopulmonary Autotransfusion Devices Product Introduction
8.3.5 LivaNova Recent Development
8.4 Medtronic
8.4.1 Medtronic Company Details
8.4.2 Company Description and Business Overview
8.4.3 Production and Revenue of Cardiopulmonary Autotransfusion Devices
8.4.4 Cardiopulmonary Autotransfusion Devices Product Introduction
8.4.5 Medtronic Recent Development
8.5 Terumo
8.5.1 Terumo Company Details
8.5.2 Company Description and Business Overview
8.5.3 Production and Revenue of Cardiopulmonary Autotransfusion Devices
8.5.4 Cardiopulmonary Autotransfusion Devices Product Introduction
8.5.5 Terumo Recent Development
8.6 Stryker
8.6.1 Stryker Company Details
8.6.2 Company Description and Business Overview
8.6.3 Production and Revenue of Cardiopulmonary Autotransfusion Devices
8.6.4 Cardiopulmonary Autotransfusion Devices Product Introduction
8.6.5 Stryker Recent Development
8.7 Atrium Medical
8.7.1 Atrium Medical Company Details
8.7.2 Company Description and Business Overview
8.7.3 Production and Revenue of Cardiopulmonary Autotransfusion Devices
8.7.4 Cardiopulmonary Autotransfusion Devices Product Introduction
8.7.5 Atrium Medical Recent Development
9 Market Forecast
9.1 Global Market Size Forecast
9.1.1 Global Cardiopulmonary Autotransfusion Devices Capacity, Production Forecast 2020-2030
9.1.2 Global Cardiopulmonary Autotransfusion Devices Production Value Forecast 2020-2030
9.2 Market Forecast by Regions
9.2.1 Global Cardiopulmonary Autotransfusion Devices Production and Value Forecast by Regions 2020-2030
9.2.2 Global Cardiopulmonary Autotransfusion Devices Consumption Forecast by Regions 2020-2030
9.3 United States
9.3.1 Production and Value Forecast in United States
9.3.2 Consumption Forecast in United States
9.4 European Union
9.4.1 Production and Value Forecast in European Union
9.4.2 Consumption Forecast in European Union
9.5 China
9.5.1 Production and Value Forecast in China
9.5.2 Consumption Forecast in China
9.6 Rest of World
9.6.1 Japan
9.6.2 Korea
9.6.3 India
9.6.4 Southeast Asia
9.7 Forecast by Type
9.7.1 Global Cardiopulmonary Autotransfusion Devices Production Forecast by Type
9.7.2 Global Cardiopulmonary Autotransfusion Devices Production Value Forecast by Type
9.8 Consumption Forecast by Application
11 Opportunities & Challenges, Threat and Affecting Factors
11.1 Market Opportunities
11.2 Market Challenges
11.3 Porters Five Forces Analysis
12 Key Findings
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
Research Methodology
The Market Research Update offers technology-driven solutions and its full integration in the research process to be skilled at every step. We use diverse assets to produce the best results for our clients. The success of a research project is completely reliant on the research process adopted by the company. Market Research Update assists its clients to recognize opportunities by examining the global market and offering economic insights. We are proud of our extensive coverage that encompasses the understanding of numerous major industry domains.
Market Research Update provide consistency in our research report, also we provide on the part of the analysis of forecast across a gamut of coverage geographies and coverage. The research teams carry out primary and secondary research to implement and design the data collection procedure. The research team then analyzes data about the latest trends and major issues in reference to each industry and country. This helps to determine the anticipated market-related procedures in the future. The company offers technology-driven solutions and its full incorporation in the research method to be skilled at each step.
The Company's Research Process Has the Following Advantages:
Information Procurement
The step comprises the procurement of market-related information or data via different methodologies & sources.
Information Investigation
This step comprises the mapping and investigation of all the information procured from the earlier step. It also includes the analysis of data differences observed across numerous data sources.
Highly Authentic Source
We offer highly authentic information from numerous sources. To fulfills the client’s requirement.
Market Formulation
This step entails the placement of data points at suitable market spaces in an effort to assume possible conclusions. Analyst viewpoint and subject matter specialist based examining the form of market sizing also plays an essential role in this step.
Validation & Publishing of Information
Validation is a significant step in the procedure. Validation via an intricately designed procedure assists us to conclude data-points to be used for final calculations.
We are flexible and responsive startup research firm. We adapt as your research requires change, with cost-effectiveness and highly researched report that larger companies can't match.
Information Safety
Market Research Update ensure that we deliver best reports. We care about the confidential and personal information quality, safety, of reports. We use Authorize secure payment process.
We Are Committed to Quality and Deadlines
We offer quality of reports within deadlines. We've worked hard to find the best ways to offer our customers results-oriented and process driven consulting services.
Our Remarkable Track Record
We concentrate on developing lasting and strong client relationship. At present, we hold numerous preferred relationships with industry leading firms that have relied on us constantly for their research requirements.
Best Service Assured
Buy reports from our executives that best suits your need and helps you stay ahead of the competition.
Customized Research Reports
Our research services are custom-made especially to you and your firm in order to discover practical growth recommendations and strategies. We don't stick to a one size fits all strategy. We appreciate that your business has particular research necessities.
Service Assurance
At Market Research Update, we are dedicated to offer the best probable recommendations and service to all our clients. You will be able to speak to experienced analyst who will be aware of your research requirements precisely.
